Lester Murray Antman Dba Simply Rich Genmab A/S Transaction History

Lester Murray Antman Dba Simply Rich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$26.83 - $38.57 $1.34 Million - $1.93 Million	-50,044 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$30.95 - $39.68 $22,686 - $29,085	733 Added 1.49%	50,044 $1.81 Million
Q4 2021 Jan 07, 2022	SELL	$35.87 - $47.12 $34,578 - $45,423	-964 Reduced 1.92%	49,311 $1.95 Million
Q3 2021 Oct 04, 2021	BUY	$41.55 - $48.72 $19,985 - $23,434	481 Added 0.97%	50,275 $2.2 Million
Q2 2021 Jul 09, 2021	BUY	$32.88 - $44.57 $76,741 - $104,026	2,334 Added 4.92%	49,794 $2.03 Million
Q1 2021 May 05, 2021	BUY	$30.92 - $44.4 $1.47 Million - $2.11 Million	47,460 New	47,460 $1.56 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Lester Murray Antman Dba Simply Rich, based on Form 13F filings with the SEC.

Stay updated on Lester Murray Antman Dba Simply Rich with notifications on news.